Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105693719A details iron-catalyzed synthesis of 3,3-spiro indolones. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN104557887B reveals a novel 1,8-naphthalimide synthesis with significant antitumor activity. Discover cost-effective manufacturing and supply chain advantages for pharmaceutical intermediates.
Patent CN107759510B enables metal-free synthesis. Delivers high-purity intermediates with reduced costs and scalable supply chain reliability for global buyers.
Patent CN108794396A details efficient oxidation of 4-oxo-2,3-dihydroquinolines. Offers high yield, low cost, and scalable supply chain solutions for pharmaceutical intermediates.
Patent CN109651421A details a ruthenium-catalyzed one-pot synthesis for high-purity pharmaceutical intermediates, offering significant cost and supply chain advantages.
Patent CN112142656B reveals a green biomass-copper catalyzed route for sulfonyl pyridine amides, offering cost-effective manufacturing and scalable pharmaceutical intermediate production.
Advanced synthesis of Belinostat intermediate II via safe esterification and HWE reactions. Reduces hazards and costs for HDAC inhibitor manufacturing.
Patent CN106188113B details water-soluble BODIPY synthesis. Offers improved purity and supply chain stability for pharmaceutical intermediate manufacturing processes.
Patent CN110563531A details a copper-catalyzed photocatalytic method for synthesizing 1,2-disubstituted olefins with high stereoselectivity and mild conditions for supply chain optimization.
Patent CN112047925B details a copper-catalyzed oxidative amination route for N-(aryl/heteroaryl) alkyl-diamides, offering significant cost reduction in API manufacturing and scalable supply chain solutions.
Patent CN114249668B reveals safer PPTS catalysis for Zolpidem intermediate. Enhances supply chain reliability and reduces manufacturing costs significantly.
Novel patent CN109280055A enables scalable ergot alkaloid production. Reduced steps and enhanced chirality control for reliable pharmaceutical intermediate supply chains.
Patent CN102584509A reveals a green iodide-catalyzed amide synthesis. Discover cost-effective manufacturing solutions for high-purity pharmaceutical intermediates.
Patent CN113185465A reveals a high-yield Stille coupling route for 4-ethyl-5-aminopyrimidine, offering significant cost reduction in pharmaceutical intermediate manufacturing through mild conditions.
Patent CN101486737A discloses a novel quaternary ammonium ferrocene ligand enabling high-yield asymmetric allylic substitution with simplified catalyst recovery for cost-effective manufacturing.
Novel 8-step synthetic route for Loxoprofen Sodium from p-methylacetophenone. High yield, solvent recovery, and scalable NSAID intermediate manufacturing technology.
Novel cyclopropanation method using diethylzinc and diiodomethane offers high yields and mild conditions for scalable API intermediate manufacturing.
Patent CN110002986A enables green water-phase oxidation. Eliminates organic solvents for cost reduction. Reliable supply chain for high-purity fluorenone intermediates.
Novel cobalt-catalyzed CO2 carboxylation patent offers cost-effective route for high-purity isonicotinic acid intermediates, enhancing supply chain reliability for global pharma manufacturing.
Patent CN102659705A reveals a novel base-mediated route for 3,4-disubstituted isoxazoles, offering high yields and simplified supply chains for drug manufacturing.